The current threat of avian influenza to the human population, the potential for the
reemergence of severe acute respiratory syndrome (SARS)-associated coronavirus, and the …

In this review, the current state of vaccine development against human severe acute
respiratory syndrome (SARS) coronavirus, focusing on recently published data is assessed …

An important effort has been performed after the emergence of severe acute respiratory
syndrome (SARS) epidemic in 2003 to diagnose and prevent virus spreading. Several types …

The emergence of the severe acute respiratory syndrome (SARS) that resulted in a
pandemic in 2003 spurred a flurry of interest in the development of vaccines to prevent and …

Although the 2003 severe acute respiratory syndrome (SARS) outbreak was controlled,
repeated transmission of SARS coronavirus (CoV) over several years makes the …

Severe acute respiratory syndrome (SARS) emerged in China and spread globally as a
human pandemic. It is caused by a new coronavirus (CoV) of suspect animal origin. The …

Severe acute respiratory syndrome (SARS) is an emerging infectious disease caused by a
new coronavirus (SARS-CoV). Recent studies suggest that SARS-CoV is zoonotic and may …

Vaccines against infectious bronchitis of chickens (Gallus gallus domesticus) have arguably
been the most successful, and certainly the most widely used, of vaccines for diseases …

In this study, we were interested in determining if high titered egg adapted modified live
infectious bronchitis virus (IBV) vaccines contain spike gene related quasispecies that …

Two novel coronaviruses have emerged in humans in the twenty-first century: severe acute
respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome …